Commerzbank Aktiengesellschaft FI Purchases 3,003 Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Commerzbank Aktiengesellschaft FI increased its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 186,966 shares of the medical instruments supplier’s stock after acquiring an additional 3,003 shares during the quarter. Commerzbank Aktiengesellschaft FI owned about 0.08% of DENTSPLY SIRONA worth $9,967,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of XRAY. Vanguard Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 7.0% in the 2nd quarter. Vanguard Group Inc. now owns 25,969,056 shares of the medical instruments supplier’s stock valued at $1,515,556,000 after purchasing an additional 1,688,546 shares in the last quarter. BlackRock Inc. boosted its stake in shares of DENTSPLY SIRONA by 3.2% in the 2nd quarter. BlackRock Inc. now owns 14,735,875 shares of the medical instruments supplier’s stock valued at $859,985,000 after purchasing an additional 458,934 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of DENTSPLY SIRONA by 1.6% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 5,471,623 shares of the medical instruments supplier’s stock valued at $319,324,000 after purchasing an additional 87,294 shares in the last quarter. Atlanta Capital Management Co. L L C boosted its stake in shares of DENTSPLY SIRONA by 0.8% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 4,673,039 shares of the medical instruments supplier’s stock valued at $272,719,000 after purchasing an additional 39,156 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of DENTSPLY SIRONA by 12.2% in the 2nd quarter. Northern Trust Corp now owns 2,919,933 shares of the medical instruments supplier’s stock valued at $170,407,000 after purchasing an additional 317,282 shares in the last quarter. Hedge funds and other institutional investors own 93.46% of the company’s stock.

Several research analysts recently issued reports on XRAY shares. Wellington Shields upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research report on Friday, August 2nd. Stifel Nicolaus upped their price target on shares of DENTSPLY SIRONA from $61.00 to $63.00 and gave the stock a “buy” rating in a research report on Friday. ValuEngine downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Evercore ISI assumed coverage on DENTSPLY SIRONA in a report on Friday, July 26th. They set an “in-line” rating for the company. Finally, Barclays boosted their price objective on DENTSPLY SIRONA from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Friday. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $57.37.

NASDAQ XRAY traded up $0.34 during trading hours on Friday, reaching $57.42. 2,699,300 shares of the company’s stock were exchanged, compared to its average volume of 1,735,074. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. DENTSPLY SIRONA Inc has a one year low of $34.93 and a one year high of $60.15. The company has a market capitalization of $12.31 billion, a price-to-earnings ratio of 28.57, a price-to-earnings-growth ratio of 1.97 and a beta of 0.96. The company’s 50-day moving average is $53.88 and its two-hundred day moving average is $54.19.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. The company had revenue of $962.10 million for the quarter, compared to analyst estimates of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.38 EPS. Research analysts predict that DENTSPLY SIRONA Inc will post 2.39 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: What is the Stochastic Momentum Index (SMI)?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.